Literature DB >> 35355776

Importance of Vitamin D3 in COVID-19 Patients.

F A Nasser1, L A Younis1, K H Abidreda1, I Alyasiri1.   

Abstract

Outbreaks of a respiratory ailment in Wuhan, China, known as the Corona virus Disease-2019 (COVID-19), began in late December 2019. Since then, several pieces of advice have been made to boost the immune system to fight more efficiently with this infection. Previously published studies showed that vitamin D3 (Vit D3) level was low in COVID-19 patients. One of the most important factors in COVID-19 severity would be the inflammatory response. It is well documented that the inflammatory cytokine storm increases the severity of COVID-19. Cytokine storm results from dysregulation of the innate immune system with an outpouring of proinflammatory cytokines and chemokines, leading to abnormal activation of the adaptive immune pathway. It has been approved that Vit D3 has immunomodulatory functions and plays an anti-inflammatory role, particularly in viral infections. Therefore, the current study was designed to investigate the possible role of Vit D3 deficiency in the COVID-19 patients' innate immunity. This study included 180 participants who were divided into group (A) consisted of 60 COVID-19 positive patients with normal level of Vit D3, group (B) consisted of 60 COVID-19 positive patients with Vit D3 deficiency, and group (C) consisted of 60 COVID-19 positive patients that had received Vit D3 therapy. The results showed that the rate of hospitalization in the group (B) (41.3%) was significantly increased, compared to group (A) (12.5%). In this regard, Vit D3 therapy led to a significant increase in the level of Vit D3, and the patients who received Vit D3 were recovered from hospital 5 days on average sooner than those in the group (B). Therefore, the consumption of Vit D3 as a daily supplement would be a reasonable suggestion for these days of the COVID-19 pandemic to increase the power of immunity of the body.

Entities:  

Keywords:  Coronavirus (COVID-19); Health; Risks; Vitamin D3

Mesh:

Substances:

Year:  2021        PMID: 35355776      PMCID: PMC8934098          DOI: 10.22092/ari.2021.356070.1769

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  14 in total

1.  IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes.

Authors:  Rudragouda Channappanavar; Anthony R Fehr; Jian Zheng; Christine Wohlford-Lenane; Juan E Abrahante; Matthias Mack; Ramakrishna Sompallae; Paul B McCray; David K Meyerholz; Stanley Perlman
Journal:  J Clin Invest       Date:  2019-07-29       Impact factor: 14.808

Review 2.  Vitamin D and the skin: an ancient friend, revisited.

Authors:  Jörg Reichrath
Journal:  Exp Dermatol       Date:  2007-07       Impact factor: 3.960

3.  Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Bi-Hua Cheng; Chao-Hung Lee
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

4.  Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure.

Authors:  Johan Moan; Alina Carmen Porojnicu; Arne Dahlback; Richard B Setlow
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-07       Impact factor: 11.205

5.  High Dose Vitamin D Administration in Ventilated Intensive Care Unit Patients: A Pilot Double Blind Randomized Controlled Trial.

Authors:  Jenny E Han; Jennifer L Jones; Vin Tangpricha; Mona A Brown; Lou Ann S Brown; Li Hao; Gautam Hebbar; Moon Jeong Lee; Shuling Liu; Thomas R Ziegler; Greg S Martin
Journal:  J Clin Transl Endocrinol       Date:  2016-05-05

6.  SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels.

Authors:  Harvey W Kaufman; Justin K Niles; Martin H Kroll; Caixia Bi; Michael F Holick
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

Review 7.  Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses.

Authors:  Shuo Su; Gary Wong; Weifeng Shi; Jun Liu; Alexander C K Lai; Jiyong Zhou; Wenjun Liu; Yuhai Bi; George F Gao
Journal:  Trends Microbiol       Date:  2016-03-21       Impact factor: 17.079

8.  Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study.

Authors:  Eugene Merzon; Dmitry Tworowski; Alessandro Gorohovski; Shlomo Vinker; Avivit Golan Cohen; Ilan Green; Milana Frenkel-Morgenstern
Journal:  FEBS J       Date:  2020-08-28       Impact factor: 5.622

Review 9.  SARS and MERS: recent insights into emerging coronaviruses.

Authors:  Emmie de Wit; Neeltje van Doremalen; Darryl Falzarano; Vincent J Munster
Journal:  Nat Rev Microbiol       Date:  2016-06-27       Impact factor: 60.633

10.  Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.

Authors:  Zhila Maghbooli; Mohammad Ali Sahraian; Mehdi Ebrahimi; Marzieh Pazoki; Samira Kafan; Hedieh Moradi Tabriz; Azar Hadadi; Mahnaz Montazeri; Mehrad Nasiri; Arash Shirvani; Michael F Holick
Journal:  PLoS One       Date:  2020-09-25       Impact factor: 3.240

View more
  1 in total

Review 1.  SARS-CoV-2 triggering autoimmune diseases.

Authors:  Leila Mobasheri; Mohammad Hossein Nasirpour; Elham Masoumi; Afsaneh Foolady Azarnaminy; Mozhdeh Jafari; Seyed-Alireza Esmaeili
Journal:  Cytokine       Date:  2022-04-05       Impact factor: 3.926

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.